Abstract: This paper develops an algorithmic solution using Ising machines to solve large-scale higher-order binary optimization (HOBO) problems with inequality constraints for resource optimization ...
A new wave of GoBruteforcer botnet malware attacks is targeting databases of cryptocurrency and blockchain projects on ...
The United States stands as the global hub of technological innovation, hosting some of the most influential Information ...
Fernando Mendoza passes for 192 yards and three touchdowns as Indiana puts on dominant display in a 38-3 College Football ...
What is a Schedule III drug — and what does Trump’s order mean for Minnesota marijuana businesses? President Donald Trump’s order starts the process of reclassifying cannabis alongside drugs with ...
The move would ease federal restrictions on the drug. President Donald Trump is expected to sign an executive order as soon as Wednesday that will reclassify marijuana to a Schedule III drug, ...
President Donald Trump signed an executive order to reclassify marijuana as a Schedule III drug. The reclassification does not legalize marijuana for recreational use at the federal level. In Florida, ...
Aaron Navarro is a CBS News digital reporter. He covered the 2024 elections and was previously an associate producer for the CBS News political unit in the 2021 and 2022 election cycles. Washington — ...
President Donald Trump signed an executive order Thursday to expedite the reclassification of marijuana – an effort to increase research on its medical use but not fully legalize it. “This ...
WASHINGTON — President Donald Trump signed an executive order Thursday to speed the reclassification of marijuana from a Schedule I drug, a significant change that would not federally legalize ...
Marijuana’s classification as one of the most dangerous and habit-forming substances has long drawn criticism. By Luke Broadwater and Ashley Southall Luke Broadwater reported from Washington, and ...
Section 1. Purpose and Policy. Americans deserve access to the best medical treatments and research infrastructure in the world. In 2023, the Food and Drug Administration (FDA) completed a review of ...